<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01008683</url>
  </required_header>
  <id_info>
    <org_study_id>engelhard-HMO-CTIL</org_study_id>
    <nct_id>NCT01008683</nct_id>
  </id_info>
  <brief_title>Antibody Production Following H1N1 Influenza Vaccination After Stem Cell and Heart Transplantation</brief_title>
  <official_title>Antibody Production Following H1N1 Influenza Vaccination After Stem Cell and Heart Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Stem cell and and heart transplant patients will receive pandemic H1N1 influenza vaccination
      according to the clinical guidelines.

      In these patients the investigators will measure the specific antibody production.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Stem cell and and heart transplant patients will receive pandemic H1N1 influenza vaccination
      according to the clinical guidelines. Two doses will be given, in 3-week interval.

      In these patients we will measure the specific antibody production. Blood sample 5 ml will be
      drawn before the first vaccine, before the second, and 3-4 weeks after the 2nd dose.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2009</start_date>
  <completion_date type="Anticipated">July 2010</completion_date>
  <primary_completion_date type="Anticipated">April 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>H1N1 Influenza</condition>
  <arm_group>
    <arm_group_label>Stem cell and and heart transplant patients</arm_group_label>
    <description>Stem cell and and heart transplant patients</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Stem cell and and heart transplant patients who will receive pandemic H1N1 influenza
        vaccination according to the clinical guidelines.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stem cell and and heart transplant patients who will receive pandemic H1N1 influenza
             vaccination according to the clinical guidelines.

        Exclusion Criteria:

          -  Patients with unstable grafts.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dan Engelhard</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hadas Lemberg</last_name>
    <email>lhadas@hadassah.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hadassah Medical Organization</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dan Engelhard</last_name>
      <email>engelhard@hadassah.org.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 5, 2009</study_first_submitted>
  <study_first_submitted_qc>November 5, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 6, 2009</study_first_posted>
  <last_update_submitted>November 5, 2009</last_update_submitted>
  <last_update_submitted_qc>November 5, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 6, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dan Engelhard</name_title>
    <organization>HMO</organization>
  </responsible_party>
  <keyword>Stem cell and and heart transplant patients who will receive pandemic H1N1 influenza vaccinations</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Influenza, Human</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antibodies</mesh_term>
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

